Market Research Logo

Female Pelvic Implants Market: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Female Pelvic Implants Market: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Vaginal slings to hold an attractive spot in the global female pelvic implants market

Female Pelvic Implants is a procedure to treat disorders such as pelvic organ prolapse and stress urinary incontinence. The three main types of products or implants used in the procedure are vaginal mesh implants, vaginal sling and vaginal graft implants. Among these, vaginal slings are expected to hold the highest market value of over US$ 188 Mn by the end of 2027. These types of implants are generally made from a narrow ‘tape’ of polypropylene mesh that is placed under the urethra like a sling or hammock to keep the urethra in the correct position. Vaginal slings have been in the market for about 20 years and can be implanted in a half-hour, minimally invasive surgical procedure under local anaesthesia as an outpatient. Vaginal grafts are also expected to be an attractive product in the market and are expected to grow at a significant rate of 3.5% during the forecast period. "


1. Executive Summary
1.1. Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Global Economic Outlook
3.1. Gross Domestic Product by Region & Country, 2006 – 2021
4. Female Pelvic Implants Market View point
4.1. Macro-Economic Factors
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity Analysis
4.2.4. Trends
5. Regulatory Challenges & Legal Challenges
5.1. Future of the Market –Pelvic Organ Prolapse
6. North America Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027
6.1. Introduction/Key Findings
6.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
6.2.1. U.S.
6.2.2. Canada
6.3. Market Size (US$ Mn) Forecast By Country, 2017–2027
6.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
6.4.1. Vaginal Mesh Implants
6.4.2. Vaginal Sling
6.4.3. Vaginal Graft Implants
6.5. Market Size (US$ Mn) Forecast By Product Type, 2017–2027
6.6. Historical Market Size (US$ Mn) Analysis By Indication Type, 2012–2016
6.6.1. Pelvic Organ Prolapse (POP)
6.6.2. Stress Urinary Incontinence (SUI)
6.7. Market Size (US$ Mn) Forecast By Indication Type, 2017–2027
6.8. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016
6.8.1. Hospitals
6.8.2. Ambulatory Surgical Centers
6.8.3. Specialty Clinics
6.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
6.10. Market Attractiveness Analysis
6.10.1. By Country
6.10.2. By Product Type
6.10.3. By Indication Type
6.10.4. By End User
6.11. Drivers and Restraints – Impact Analysis
7. Latin America Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027
7.1. Introduction/Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Market Size (US$ Mn) Forecast By Country, 2017–2027
7.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
7.4.1. Vaginal Mesh Implants
7.4.2. Vaginal Sling
7.4.3. Vaginal Graft Implants
7.5. Market Size (US$ Mn) Forecast By Product Type, 2017–2027
7.6. Historical Market Size (US$ Mn) Analysis By Indication Type, 2012–2016
7.6.1. Pelvic Organ Prolapse (POP)
7.6.2. Stress Urinary Incontinence (SUI)
7.7. Market Size (US$ Mn) Forecast By Indication Type, 2017–2027
7.8. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016
7.8.1. Hospitals
7.8.2. Ambulatory Surgical Centers
7.8.3. Specialty Clinics
7.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
7.10. Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Product Type
7.10.3. By Indication Type
7.10.4. By End User
7.11. Drivers and Restraints – Impact Analysis
8. Western Europe Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027
8.1. Introduction/Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
8.2.1. Germany
8.2.2. Italy
8.2.3. France
8.2.4. Spain
8.2.5. U.K.
8.2.6. BENELUX
8.2.7. Nordic
8.2.8. Rest of Western Europe
8.3. Market Size (US$ Mn) Forecast By Country, 2017–2027
8.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
8.4.1. Vaginal Mesh Implants
8.4.2. Vaginal Sling
8.4.3. Vaginal Graft Implants
8.5. Market Size (US$ Mn) Forecast By Product Type, 2017–2027
8.6. Historical Market Size (US$ Mn) Analysis By Indication Type, 2012–2016
8.6.1. Pelvic Organ Prolapse (POP)
8.6.2. Stress Urinary Incontinence (SUI)
8.7. Market Size (US$ Mn) Forecast By Indication Type, 2017–2027
8.8. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016
8.8.1. Hospitals
8.8.2. Ambulatory Surgical Centers
8.8.3. Specialty Clinics
8.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
8.10. Market Attractiveness Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Indication Type
8.10.4. By End User
8.11. Drivers and Restraints – Impact Analysis
9. Eastern Europe Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027
9.1. Introduction/Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
9.2.1. Russia
9.2.2. Poland
9.2.3. Rest of Eastern Europe
9.3. Market Size (US$ Mn) Forecast By Country, 2017–2027
9.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
9.4.1. Vaginal Mesh Implants
9.4.2. Vaginal Sling
9.4.3. Vaginal Graft Implants
9.5. Market Size (US$ Mn) Forecast By Product Type, 2017–2027
9.6. Historical Market Size (US$ Mn) Analysis By Indication Type, 2012–2016
9.6.1. Pelvic Organ Prolapse (POP)
9.6.2. Stress Urinary Incontinence (SUI)
9.7. Market Size (US$ Mn) Forecast By Indication Type, 2017–2027
9.8. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016
9.8.1. Hospitals
9.8.2. Ambulatory Surgical Centers
9.8.3. Specialty Clinics
9.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
9.10. Market Attractiveness Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Indication Type
9.10.4. By End User
9.11.Drivers and Restraints – Impact Analysis
10. Asia Pacific excluding China and Japan Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027
10.1. Introduction/Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
10.2.1. India
10.2.2. ASEAN
10.2.3. Australia and New Zealand
10.2.4. Rest of APEJ
10.3. Market Size (US$ Mn) Forecast By Country, 2017–2027
10.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
10.4.1. Vaginal Mesh Implants
10.4.2. Vaginal Sling
10.4.3. Vaginal Graft Implants
10.5. Market Size (US$ Mn) Forecast By Product Type, 2017–2027
10.6. Historical Market Size (US$ Mn) Analysis By Indication Type, 2012–2016
10.6.1. Pelvic Organ Prolapse (POP)
10.6.2. Stress Urinary Incontinence (SUI)
10.7. Market Size (US$ Mn) Forecast By Indication Type, 2017–2027
10.8. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016
10.8.1. Hospitals
10.8.2. Ambulatory Surgical Centers
10.8.3. Specialty Clinics
10.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
10.10. Market Attractiveness Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Indication Type
10.10.4. By End User
10.11. Drivers and Restraints – Impact Analysis
11. China Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027
11.1. Introduction/Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
11.2.1. Vaginal Mesh Implants
11.2.2. Vaginal Sling
11.2.3. Vaginal Graft Implants
11.3. Market Size (US$ Mn) Forecast By Product Type, 2017–2027
11.4. Historical Market Size (US$ Mn) Analysis By Indication Type, 2012–2016
11.4.1. Pelvic Organ Prolapse (POP)
11.4.2. Stress Urinary Incontinence (SUI)
11.5. Market Size (US$ Mn) Forecast By Indication Type, 2017–2027
11.6. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016
11.6.1. Hospitals
11.6.2. Ambulatory Surgical Centers
11.6.3. Specialty Clinics
11.7. Market Size (US$ Mn) Forecast By End User, 2017–2027
11.8. Market Attractiveness Analysis
11.8.1. By Product Type
11.8.2. By Indication Type
11.8.3. By End User
11.9.Drivers and Restraints – Impact Analysis
12. Japan Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027
12.1. Introduction/Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
12.2.1. Vaginal Mesh Implants
12.2.2. Vaginal Sling
12.2.3. Vaginal Graft Implants
12.3. Market Size (US$ Mn) Forecast By Product Type, 2017–2027
12.4. Historical Market Size (US$ Mn) Analysis By Indication Type, 2012–2016
12.4.1. Pelvic Organ Prolapse (POP)
12.4.2. Stress Urinary Incontinence (SUI)
12.5. Market Size (US$ Mn) Forecast By Indication Type, 2017–2027
12.6. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016
12.6.1. Hospitals
12.6.2. Ambulatory Surgical Centers
12.6.3. Specialty Clinics
12.7. Market Size (US$ Mn) Forecast By End User, 2017–2027
12.8. Market Attractiveness Analysis
12.8.1. By Product Type
12.8.2. By Indication Type
12.8.3. By End User
12.9. Drivers and Restraints – Impact Analysis
13. Middle East & Africa Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027
13.1. Introduction/Key Findings
13.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
13.2.1. GCC Countries
13.2.2. South Africa
13.2.3. Rest of MEA
13.3. Market Size (US$ Mn) Forecast By Country, 2017–2027
13.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
13.4.1. Vaginal Mesh Implants
13.4.2. Vaginal Sling
13.4.3. Vaginal Graft Implants
13.5. Market Size (US$ Mn) Forecast By Product Type, 2017–2027
13.6. Historical Market Size (US$ Mn) Analysis By Indication Type, 2012–2016
13.6.1. Pelvic Organ Prolapse (POP)
13.6.2. Stress Urinary Incontinence (SUI)
13.7. Market Size (US$ Mn) Forecast By Indication Type, 2017–2027
13.8. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016
13.8.1. Hospitals
13.8.2. Ambulatory Surgical Centers
13.8.3. Specialty Clinics
13.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
13.10. Drivers and Restraints: Impact Analysis
13.11. Market Attractiveness Analysis
13.11.1. By Country
13.11.2. By Product Type
13.11.3. By Indication Type
13.11.4. By End User
13.12. Drivers and Restraints – Impact Analysis
14. Forecast Factors: Relevance and Impact
15. Market Structure Analysis
15.1. Market Structure by Tier of Companies
16. Competition Analysis
16.1. Competition Dashboard
16.2. Company Deep Dive
16.2.1. Johnson & Johnson
16.2.2. Coloplast A/S
16.2.3. Becton, Dickinson and Company (C.R. Bard, Inc.)
16.2.4. Boston Scientific Corporation
16.2.5. pfm medical ag
16.2.6. Cook Medical
16.2.7. Betatech Medical
16.2.8. Dipromed Srl
16.2.9. Promedon Group
16.2.10. Caldera Medical
17. Global Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027, By Region
17.1. Introduction/Key Findings
17.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
17.3. Market Size (US$ Mn) Forecast By Region, 2017–2027
17.3.1. North America
17.3.2. Latin America
17.3.3. Western Europe
17.3.4. Eastern Europe
17.3.5. Asia Pacific excluding Japan
17.3.6. Japan
17.3.7. China
17.3.8. Middle East & Africa
17.4. Market Attractiveness Analysis By Region
18. Global Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027, By Product Type
18.1. Introduction/Key Findings
18.2. Historical Market Size (US$ Mn) and Trend Analysis By Product Type, 2012–2016
18.2.1. Vaginal Mesh Implants
18.2.2. Vaginal Sling
18.2.3. Vaginal Graft Implants
18.3. Market Size (US$ Mn) and Forecast By Product Type, 2017–2027
18.4. Market Attractiveness Analysis By Product Type
19. Global Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027, By Indication Type
19.1. Introduction/Key Findings
19.2. Historical Market Size (US$ Mn) and Trend Analysis By Indication Type, 2012–2016
19.2.1. Pelvic Organ Prolapse (POP)
19.2.2. Stress Urinary Incontinence (SUI)
19.3. Market Size (US$ Mn) and Forecast By Indication Type, 2017–2027
19.4. Market Attractiveness Analysis By Indication Type
20. Global Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027, By End User
20.1. Introduction/Key Findings
20.2. Historical Market Size (US$ Mn) and Trend Analysis By End User, 2012–2016
20.2.1. Hospitals
20.2.2. Ambulatory Surgical Centers
20.2.3. Specialty Clinics
20.3. Market Size (US$ Mn) and Forecast By End User, 2017–2027
20.4. Market Attractiveness Analysis By End User
21. Global Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027
21.1. Market Size and Y-o-Y Growth
21.2. Absolute $ Opportunity

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report